These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 38166752)
21. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892 [TBL] [Abstract][Full Text] [Related]
22. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer. Xiong H; Shen J; Chen Z; Yang J; Xie B; Jia Y; Jayasinghe U; Wang J; Zhao W; Xie S; Wang L; Zhou J Int J Oncol; 2020 Mar; 56(3):794-806. PubMed ID: 32124962 [TBL] [Abstract][Full Text] [Related]
23. The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer. Zhou X; Ye F; Yin C; Zhuang Y; Yue G; Zhang G Cell Physiol Biochem; 2015; 36(4):1440-52. PubMed ID: 26160158 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers. Lin X; Qiu J; Hua K Biosci Trends; 2018 Sep; 12(4):342-353. PubMed ID: 30146551 [TBL] [Abstract][Full Text] [Related]
25. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer. Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182 [TBL] [Abstract][Full Text] [Related]
26. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers. Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619 [TBL] [Abstract][Full Text] [Related]
27. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Yan L; Zhou J; Gao Y; Ghazal S; Lu L; Bellone S; Yang Y; Liu N; Zhao X; Santin AD; Taylor H; Huang Y Oncogene; 2015 Jun; 34(23):3076-84. PubMed ID: 25088204 [TBL] [Abstract][Full Text] [Related]
28. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function. Zhao Y; Feng C; Li Y; Ma Y; Cai R Mol Cell Biochem; 2019 Oct; 460(1-2):1-8. PubMed ID: 31187349 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. Li Z; Li Y; Li Y; Ren K; Li X; Han X; Wang J J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544374 [TBL] [Abstract][Full Text] [Related]
30. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related]
31. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183 [TBL] [Abstract][Full Text] [Related]
32. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells. Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782 [TBL] [Abstract][Full Text] [Related]
33. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer. Gan L; Lv L; Liao S Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061 [TBL] [Abstract][Full Text] [Related]
34. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3. Liu L; Liu L; Lu S Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209 [TBL] [Abstract][Full Text] [Related]
35. Huaier Extract Inhibits Breast Cancer Progression Through a LncRNA-H19/MiR-675-5p Pathway. Wang J; Wang X; Chen T; Jiang L; Yang Q Cell Physiol Biochem; 2017; 44(2):581-593. PubMed ID: 29145193 [TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a. Jia P; Cai H; Liu X; Chen J; Ma J; Wang P; Liu Y; Zheng J; Xue Y Cancer Lett; 2016 Oct; 381(2):359-69. PubMed ID: 27543358 [TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes. Dong P; Xiong Y; Yue J; Xu D; Ihira K; Konno Y; Kobayashi N; Todo Y; Watari H J Exp Clin Cancer Res; 2019 Jul; 38(1):295. PubMed ID: 31287002 [TBL] [Abstract][Full Text] [Related]
38. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19. Wang N; Hou M; Zhan Y; Sheng X J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090 [TBL] [Abstract][Full Text] [Related]
39. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis. Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707 [TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p. Zheng JF; Guo NH; Zi FM; Cheng J Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]